Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | No | Yes |
| Is net profit margin increasing? | Yes | Yes |
| Is asset turnover increasing? | Yes | Yes |
| Is equity multiplier increasing? | Yes | No |
| Competitors Used |
|---|
| HeraMED Limited |
| Nanosonics Limited |
| Micro-X Limited |
| Resonance Health Limited |
| Nova Eye Medical Limited |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| HMD | NAN | MX1 | RHT | EYE | CSX | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -318% | 9% | -134% | -3% | -50% | -8% | ||
| Fiscal Year - 1 | -277% | 13% | -59% | -8% | -57% | -31% | ||
| Fiscal Year - 2 | -353% | 3% | -64% | -10% | -23% | -32% | ||
| Fiscal Year - 3 | -643% | 7% | -60% | 5% | -6% | 48% | ||
| Fiscal Year - 4 | -145% | 9% | -169% | -9% | -12% | 157% | ||
| Fiscal Year - 5 | -93% | 13% | 531% | 25% | -9% | -82% | ||
| Average | -305% | 9% | 7% | 0% | -26% | 9% | ||
| Median | -297% | 9% | -62% | -5% | -18% | -20% | ||
| Benchmarks | Ticker | |||||||
| HeraMED Limited | ASX:HMD | |||||||
| Nanosonics Limited | ASX:NAN | |||||||
| Micro-X Limited | ASX:MX1 | |||||||
| Resonance Health Limited | ASX:RHT | |||||||
| Nova Eye Medical Limited | ASX:EYE | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | HMD | NAN | MX1 | RHT | EYE | CSX | ||
| Latest Fiscal Year | Dec-24 | Jun-24 | Jun-24 | Jun-24 | Jun-24 | Jun-24 | ||
| LTM Period | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 0 | 184 | 14 | 11 | 26 | 18 | ||
| Fiscal Year | 0 | 170 | 15 | 9 | 23 | 16 | ||
| Fiscal Year - 1 | 1 | 166 | 15 | 4 | 17 | 12 | ||
| Fiscal Year - 2 | 0 | 120 | 9 | 4 | 13 | 13 | ||
| Fiscal Year - 3 | 0 | 103 | 4 | 4 | 13 | 50 | ||
| Fiscal Year - 4 | 0 | 100 | 4 | 4 | 13 | 28 | ||
| Fiscal Year - 5 | 0 | 84 | 2 | 4 | 16 | 11 | ||
| Net Income | ||||||||
| Latest Twelve Months | (5) | 17 | (11) | (0) | (9) | (1) | ||
| Fiscal Year | (5) | 13 | (10) | 0 | (9) | (3) | ||
| Fiscal Year - 1 | (7) | 20 | (11) | (1) | (15) | (8) | ||
| Fiscal Year - 2 | (7) | 4 | (17) | (1) | (7) | (11) | ||
| Fiscal Year - 3 | (8) | 9 | (15) | 1 | (4) | 11 | ||
| Fiscal Year - 4 | (4) | 10 | (10) | (1) | (10) | 6 | ||
| Fiscal Year - 5 | (4) | 14 | (10) | 1 | (7) | (1) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 3 | 227 | 22 | 11 | 24 | 27 | ||
| Latest Fiscal Quarter | 4 | 255 | 20 | 18 | 26 | 25 | ||
| Fiscal Year | 4 | 237 | 27 | 20 | 30 | 26 | ||
| Fiscal Year - 1 | 3 | 220 | 30 | 11 | 30 | 29 | ||
| Fiscal Year - 2 | 6 | 187 | 31 | 12 | 37 | 38 | ||
| Fiscal Year - 3 | 6 | 162 | 45 | 12 | 42 | 51 | ||
| Fiscal Year - 4 | 4 | 147 | 34 | 10 | 117 | 23 | ||
| Fiscal Year - 5 | 5 | 130 | 10 | 6 | 100 | 8 | ||
| Fiscal Year - 6 | 8 | 109 | 15 | 5 | 103 | 8 | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 1 | 176 | 10 | 10 | 17 | 20 | ||
| Latest Fiscal Quarter | 3 | 189 | 6 | 10 | 17 | 19 | ||
| Fiscal Year | 3 | 182 | 14 | 11 | 21 | 19 | ||
| Fiscal Year - 1 | 1 | 164 | 17 | 10 | 23 | 22 | ||
| Fiscal Year - 2 | 4 | 139 | 19 | 11 | 30 | 30 | ||
| Fiscal Year - 3 | (0) | 136 | 34 | 12 | 35 | 41 | ||
| Fiscal Year - 4 | 3 | 124 | 15 | 10 | 101 | 7 | ||
| Fiscal Year - 5 | 3 | 110 | (3) | 6 | 69 | 1 | ||
| Fiscal Year - 6 | 6 | 94 | (1) | 4 | 73 | 2 | ||